Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Genetic Signatures Ltd. ( (AU:GSS) ) just unveiled an update.
Genetic Signatures Ltd. announced the cessation of 240,000 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This development may affect the company’s capital structure and could have implications for its financial strategy and stakeholder interests.
The most recent analyst rating on (AU:GSS) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on Genetic Signatures Ltd. stock, see the AU:GSS Stock Forecast page.
More about Genetic Signatures Ltd.
Genetic Signatures Ltd. operates in the biotechnology industry, focusing on the development of molecular diagnostics products. The company is known for its innovative solutions aimed at simplifying and accelerating the detection of infectious diseases, catering primarily to clinical laboratories and healthcare providers.
Average Trading Volume: 160,561
Technical Sentiment Signal: Sell
Current Market Cap: A$86.31M
For detailed information about GSS stock, go to TipRanks’ Stock Analysis page.